Evidence map›Paper›PMID 30090244›Full record

ArticleChemical science2015

Hai-Yu Hu, Ngee-Han Lim, Hans-Paul Juretschke, Danping Ding-Pfennigdorff, Peter Florian, Markus Kohlmann, Abdullah Kandira, Jens Peter von Kries, Joachim Saas, Karl A Rudolphi and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. A review of advanced hydrogels for cartilage tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  2. Review
  3. Biomaterial strategies for improved intra-articular drug delivery.Journal of biomedical materials research. Part A · 2021
    Review
  4. Review
  5. Targeting Cartilage Degradation in Osteoarthritis.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 5 countries.

Hai-Yu HuEuropean Molecular Biology Laboratory (EMBL) , Interdisciplinary Chemistry Group , Cell Biology and Biophysics Unit , Meyerhofstr. 1 , 69117 Heidelberg , Germany . Email: schultz@embl.de.
Ngee-Han LimKennedy Institute of Rheumatology , University of Oxford , Roosevelt Drive , Headington , Oxford OX37FY , UK.
Hans-Paul JuretschkeSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Danping Ding-PfennigdorffSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Peter FlorianSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Markus KohlmannSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Abdullah KandiraSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Jens Peter von KriesSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Joachim SaasSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Karl A RudolphiSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
K Ulrich WendtSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Hideaki NagaseSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Oliver PlettenburgSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Marc NazareSanofi-Aventis Deutschland GmbH , Industriepark Hoechst , 65962 Frankfurt , Germany.
Carsten SchultzEuropean Molecular Biology Laboratory (EMBL) , Interdisciplinary Chemistry Group , Cell Biology and Biophysics Unit , Meyerhofstr. 1 , 69117 Heidelberg , Germany . Email: schultz@embl.de.
Sanofi (Germany) · DEEuropean Molecular Biology Laboratory · DEInstitute of Rheumatology · CZLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is one of the most common diseases in the aging population. While disease progress in humans is monitored indirectly by X-ray or MRI, small animal OA lesions detection always requires surgical intervention and histology. Here we introduce bimodal MR/NIR probes based on cartilage-targeting 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid amide (DOTAM) that are directly administered to the joint cavity. We demonstrate applications in healthy and diseased rat joints by MRI

Identifiers

PMID30090244
PMCPMC6054140
OpenAlexW1809527858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.